About Thirty Madison
Thirty Madison is a company based in New York (United States) founded in 2017 by Steven Gutentag and Demetri Karagas was acquired by Remedy Meds in September 2025. Thirty Madison has raised $206 million across 4 funding rounds from investors including Health Quest Capital, Bracket Capital and Mousse Partners. Thirty Madison operates in a competitive market with competitors including Nurx, Icebreaker Health, PipelineRx, Medly Pharmacy and Apostrophe, among others.
- Headquarter New York, United States
- Founders Steven Gutentag, Demetri Karagas
- Stage Unicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$206 M (USD)
in 4 rounds
-
Latest Funding Round
$141 M (USD), Series C
Jun 02, 2021
-
Investors
Health Quest Capital
& 14 more
-
Employee Count
Not available
-
Acquired by
Remedy Meds
(Sep 03, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Thirty Madison
Unlock access to complete
Unlock access to complete
Funding Insights of Thirty Madison
Thirty Madison has successfully raised a total of $206M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $141 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Thirty Madison
Thirty Madison has secured backing from 15 investors, including venture fund and angel investors. Prominent investors backing the company include Health Quest Capital, Bracket Capital and Mousse Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are focused on tech and life sciences startups.
|
Locked | Locked | Locked | |
|
Multi-asset investment management is provided for technology-enabled companies.
|
Locked | Locked | Locked | |
|
Venture capital fund focused on multiple sectors
|
Locked | Locked | Locked |
Investor details for Thirty Madison
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Thirty Madison
Investment portfolio details for Thirty Madison
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Thirty Madison
Detailed financials for Thirty Madison
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Thirty Madison Comparisons
Peer comparison for Thirty Madison
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Thirty Madison
Thirty Madison operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nurx, Icebreaker Health, PipelineRx, Medly Pharmacy and Apostrophe, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Online prescriptions and delivery of contraceptives and PrEP are facilitated.
|
|
| Locked | Locked | Locked |
Provider of remote patient consultation services and online delivery of medical care products
|
|
| Locked | Locked | Locked |
24/7 telepharmacy and software solution provider
|
|
| Locked | Locked | Locked |
Functions as an online pharmacy specializing in prescribed medicines.
|
|
| Locked | Locked | Locked |
An online platform for dermatology diagnosis and treatment is offered.
|
Detailed competitors of Thirty Madison
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Thirty Madison
Complete news archive for Thirty Madison
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Thirty Madison
Thirty Madison was founded in 2017.
Thirty Madison is headquartered in New York, United States. It is registered at New York, New York, United States.
Steven Gutentag is the current CEO of Thirty Madison. They have also founded this company.
Thirty Madison is a funded company, having raised a total of $206M across 4 funding rounds to date.
Founded in 2017 and based in New York, United States, Thirty Madison operates as a virtual-first healthcare platform. Specialized brands are offered for conditions such as mens hair loss through Keeps, migraines via Cove, allergies with Picnic, skin issues by Facet, and sexual health via NURX. Chronic conditions are addressed through accessible, tailored virtual services across the United States.
Thirty Madison's top competitors include Icebreaker Health, Nurx and Apostrophe.
Thirty Madison has 15 investors. Key investors include Health Quest Capital, Bracket Capital, Mousse Partners, Polaris Partners, and Johnson & Johnson Innovation – JJDC.
The valuation of Thirty Madison is $1B as of Jun 2021.